Blue Light Deprivation Produces Depression-Like Responses in Mongolian Gerbils.

HPA axis blue light depression gerbils melatonin

Journal

Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006

Informations de publication

Date de publication:
2020
Historique:
received: 05 11 2019
accepted: 10 03 2020
entrez: 24 4 2020
pubmed: 24 4 2020
medline: 24 4 2020
Statut: epublish

Résumé

Depression is a leading cause of disability worldwide and is a major contributor to the overall global burden of disease, but its etiology is poorly understood. It has been reported that a disrupted biological rhythm, in terms of a shortened light duration and total darkness, can cause depression-like behaviors in animals. Blue light was reported to have an inhibitory effect on melatonin, which is considered an important clock rhythm biomarker. In the present study, we investigated the effects of blue light deprivation on depressive-like behaviors in gerbils and explored the underlying mechanisms. Gerbils were housed under white light with a filter to block the blue light or without a filter. The behaviors of the gerbils were observed. The biological rhythm, 5-HT, hypothalamic-pituitary-adrenal (HPA) axis and melanopsin pathway were analyzed. We found that blue light deprivation (BLD) induced depression-like behavior in gerbils. Melatonin lost its rhythm, and corticosterone (CORT) levels decreased in the morning in the BLD group. Lower corticotropin-releasing hormone (CRH) in the hypothalamus and lower adrenocorticotropin hormone (ACTH)/CORT in serum were observed after BLD. Furthermore, 5-HT in the serum and brain were decreased after BLD. Additionally, BLD affected the blue light sensitivity protein melanopsin and its pathway, with downregulation of the proteins melanopsin, PKCα, and c-Fos and the mRNA levels of Our findings indicated that BLD might produce depression-like behaviors in gerbils. Melatonin arrhythmicity, HPA axis abnormalities, 5-HT decreases and melanopsin pathway changes might be associated with the depression behavioral phenotype in gerbils.

Sections du résumé

BACKGROUND BACKGROUND
Depression is a leading cause of disability worldwide and is a major contributor to the overall global burden of disease, but its etiology is poorly understood. It has been reported that a disrupted biological rhythm, in terms of a shortened light duration and total darkness, can cause depression-like behaviors in animals. Blue light was reported to have an inhibitory effect on melatonin, which is considered an important clock rhythm biomarker. In the present study, we investigated the effects of blue light deprivation on depressive-like behaviors in gerbils and explored the underlying mechanisms.
METHODS METHODS
Gerbils were housed under white light with a filter to block the blue light or without a filter. The behaviors of the gerbils were observed. The biological rhythm, 5-HT, hypothalamic-pituitary-adrenal (HPA) axis and melanopsin pathway were analyzed.
RESULTS RESULTS
We found that blue light deprivation (BLD) induced depression-like behavior in gerbils. Melatonin lost its rhythm, and corticosterone (CORT) levels decreased in the morning in the BLD group. Lower corticotropin-releasing hormone (CRH) in the hypothalamus and lower adrenocorticotropin hormone (ACTH)/CORT in serum were observed after BLD. Furthermore, 5-HT in the serum and brain were decreased after BLD. Additionally, BLD affected the blue light sensitivity protein melanopsin and its pathway, with downregulation of the proteins melanopsin, PKCα, and c-Fos and the mRNA levels of
CONCLUSIONS CONCLUSIONS
Our findings indicated that BLD might produce depression-like behaviors in gerbils. Melatonin arrhythmicity, HPA axis abnormalities, 5-HT decreases and melanopsin pathway changes might be associated with the depression behavioral phenotype in gerbils.

Identifiants

pubmed: 32322220
doi: 10.3389/fpsyt.2020.00233
pmc: PMC7156555
doi:

Types de publication

Journal Article

Langues

eng

Pagination

233

Informations de copyright

Copyright © 2020 Hu, Kang, Hou, Zhang, Meng, Jiang and Hao.

Références

PLoS One. 2012;7(9):e45387
pubmed: 23049792
Arch Gen Psychiatry. 1990 May;47(5):411-8
pubmed: 2184795
J Psychiatry Neurosci. 2007 Jan;32(1):23-9
pubmed: 17245471
Neuron. 1990 Apr;4(4):477-85
pubmed: 1969743
Philos Trans R Soc Lond B Biol Sci. 2012 Sep 5;367(1601):2444-59
pubmed: 22826344
Mol Psychiatry. 2013 Jun;18(6):692-9
pubmed: 23089630
Bioelectromagnetics. 2016 Apr;37(3):175-182
pubmed: 26969907
Am J Ophthalmol. 2008 Sep;146(3):404-9
pubmed: 18602079
Physiol Behav. 2007 Dec 5;92(5):800-6
pubmed: 17628617
Psychiatry Clin Neurosci. 2020 Feb;74(2):112-117
pubmed: 31599111
Curr Biol. 2003 Aug 5;13(15):1269-78
pubmed: 12906786
Nature. 2012 Nov 22;491(7425):594-8
pubmed: 23151476
Horm Behav. 2017 Aug;94:114-123
pubmed: 28729017
J Affect Disord. 2018 Jun;233:45-67
pubmed: 29150144
J Biol Chem. 2014 Dec 19;289(51):35482-93
pubmed: 25378407
Neuron. 2005 Dec 22;48(6):987-99
pubmed: 16364902
Proc Natl Acad Sci U S A. 2006 May 9;103(19):7414-9
pubmed: 16648247
Depress Anxiety. 2019 Oct;36(10):975-986
pubmed: 31348850
Eur Neuropsychopharmacol. 2009 Apr;19(4):266-82
pubmed: 19181488
J Neural Transm (Vienna). 2015 Aug;122 Suppl 1:S35-45
pubmed: 24352409
Eur Neuropsychopharmacol. 2004 Aug;14(4):347-51
pubmed: 15163447
Behav Pharmacol. 2003 Feb;14(1):87-95
pubmed: 12576885
Brain Struct Funct. 2016 Sep;221 Suppl 1:1-272
pubmed: 27507296
Nature. 2011 Nov 02;479(7371):67-73
pubmed: 22051675
J Pineal Res. 2019 May;66(4):e12562
pubmed: 30697806
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
J Psychopharmacol. 2016 Jan;30(1):13-22
pubmed: 26464458
Biochemistry. 1996 Nov 5;35(44):13871-7
pubmed: 8909283
Brain Res. 1999 Jan 30;817(1-2):93-103
pubmed: 9889333
Biol Psychiatry. 2014 Aug 1;76(3):223-30
pubmed: 24209776
Psychoneuroendocrinology. 2005 Jun;30(5):438-52
pubmed: 15721056
Photochem Photobiol Sci. 2018 Apr 18;17(4):386-394
pubmed: 29404551
Mol Psychiatry. 2015 Feb;20(1):32-47
pubmed: 25486982
Proc Natl Acad Sci U S A. 2015 Feb 24;112(8):2557-62
pubmed: 25675490
Psychopharmacology (Berl). 1995 Sep;121(1):66-72
pubmed: 8539342
Neuropsychopharmacology. 1997 May;16(5):333-8
pubmed: 9109104
J Psychiatr Res. 2017 Apr;87:61-70
pubmed: 28017916
Horm Metab Res. 2011 May;43(5):337-42
pubmed: 21332028
J Clin Oncol. 2002 May 15;20(10):2575-601
pubmed: 12011138
Psychopharmacology (Berl). 1985;85(3):367-70
pubmed: 3923523
Chronobiol Int. 2016 Aug 5;33(9):1267-1279
pubmed: 27494399
Science. 1965 Jun 11;148(3676):1427-32
pubmed: 14294139
Depress Anxiety. 2009;26(3):273-8
pubmed: 19016463
Dialogues Clin Neurosci. 2008;10(3):329-36
pubmed: 18979946
J Biol Rhythms. 2005 Aug;20(4):314-25
pubmed: 16077151
J Physiol Pharmacol. 2006 Nov;57 Suppl 5:19-39
pubmed: 17218758
Front Psychiatry. 2020 Jan 28;10:1003
pubmed: 32047446
Science. 2005 Jan 28;307(5709):600-4
pubmed: 15681390
Physiol Behav. 2007 Feb 28;90(2-3):325-33
pubmed: 17084868
Neuropsychopharmacology. 2013 Jun;38(7):1163-75
pubmed: 23370156
Nature. 2005 Feb 17;433(7027):749-54
pubmed: 15716953
Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4898-903
pubmed: 18347342
Psychosom Med. 2011 Feb-Mar;73(2):114-26
pubmed: 21257974
Sleep Med. 2012 Feb;13(2):167-71
pubmed: 22206710
Fortschr Neurol Psychiatr. 2013 Feb;81(2):104-16; quiz 117-8
pubmed: 23412962
Behav Brain Res. 2011 Nov 20;225(1):135-41
pubmed: 21767575
Mol Psychiatry. 2002;7(3):254-75
pubmed: 11920153
J Appl Physiol (1985). 2006 Jun;100(6):1867-75
pubmed: 16439512
Circ Res. 2016 Oct 14;119(9):1017-1029
pubmed: 27650557
Br J Psychiatry. 1988 Feb;152:260-5
pubmed: 3167344
Neuroscience. 2014 Jul 11;272:252-60
pubmed: 24813431
Chronobiol Int. 2019 Jul;36(7):919-926
pubmed: 30983429
Psychoneuroendocrinology. 2011 Jul;36(6):816-23
pubmed: 21145663
Cell Transplant. 2011;20(6):871-81
pubmed: 21054936
Exp Eye Res. 2010 Feb;90(2):244-53
pubmed: 19878674
J Neurosci. 2011 Nov 9;31(45):16094-101
pubmed: 22072661
Behav Brain Res. 2006 Oct 2;173(1):153-7
pubmed: 16831474
J Clin Endocrinol Metab. 2003 Sep;88(9):4502-5
pubmed: 12970330
Int J Neuropsychopharmacol. 2009 Feb;12(1):83-93
pubmed: 18631427

Auteurs

Hong Hu (H)

Department of Toxicology, School of Public Health, Peking University, Beijing, China.
Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Beijing, China.

Chenping Kang (C)

Department of Toxicology, School of Public Health, Peking University, Beijing, China.
Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Beijing, China.

Xiaohong Hou (X)

Department of Toxicology, School of Public Health, Peking University, Beijing, China.
Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Beijing, China.

Qi Zhang (Q)

Department of Toxicology, School of Public Health, Peking University, Beijing, China.
Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Beijing, China.

Qinghe Meng (Q)

Department of Toxicology, School of Public Health, Peking University, Beijing, China.
Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Beijing, China.

Jianjun Jiang (J)

Department of Toxicology, School of Public Health, Peking University, Beijing, China.
Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Beijing, China.

Weidong Hao (W)

Department of Toxicology, School of Public Health, Peking University, Beijing, China.
Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Beijing, China.

Classifications MeSH